A new approach to managing chemotherapy-related anemia: nursing implications of epoetin alfa
Rieger, P.T.; Haeuber, D.
Oncology Nursing Forum 22(1): 71-81
1995
ISSN/ISBN: 0190-535X PMID: 7708526 Document Number: 449048
To review the role of epoetin alfa (recombinant human erythropoietin) in the treatment of chemotherapy-related anemia and the nursing management of patients receiving this form of therapy. Published books, journal articles, and monographs as well as clinical experience. Anemia is a common problem for patients with cancer. Successful management of anemia associated with cancer chemotherapy can lead to improved quality of life for patients during therapy. The use of epoetin alfa to treat the anemia associated with cancer chemotherapy represents a viable new therapeutic alternative to the use of transfusions. Oncology nurses play an important role in shaping care strategies for patients receiving cancer therapy. The nurse's role in assessment, administration, monitoring and patient education provides the foundation for effective management of patients receiving epoetin alfa therapy.